Clinical Trial Update: Semaglutide in Treatment of Obesity [Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 3 study evaluating semaglutide for obesity treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Weight Management | Phase 3 | Status: COMPLETED